Lee Greenberger

Lee Greenberger

International Waldenstrom's Macroglobulinemia Foundation

Breakthrough COVID-19 Infections in Patients with Blood Cancer - Dr. Lee Greenberger ASH 2022

Lee Greenberger Discusses Blood Cancer Research and the Leukemia and Lymphoma Society

Lee Greenberger, Chief Scientific Officer of LLS

International Waldenstrom's Macroglobulinemia Foundation

COVID-19 vaccination response in patients with hematologic malignancies from the LLS Registry

VJHemOnc – Video Journal of Hematology & HemOnc

Real-world incidence of ibrutinib-related cardiotoxicity in CLL: insights from the LLS registry

VJHemOnc – Video Journal of Hematology & HemOnc

The aims and projects of the Leukemia & Lymphoma society

VJHemOnc – Video Journal of Hematology & HemOnc

Lee Greenberger on Newly Approved Drugs for Multiple Myeloma

Insights into how COVID-19 will continue to impact patients with hematological malignancies

VJHemOnc – Video Journal of Hematology & HemOnc

Addressing cardiovascular AEs associated with BTKi treatment in patients with CLL

VJHemOnc – Video Journal of Hematology & HemOnc

The impact of booster vaccinations on SARS-CoV-2 antibody levels in patients with WM

VJHemOnc – Video Journal of Hematology & HemOnc

Leukemia & Lymphoma Society - Transforming Cures Initiative for Myeloid Blood Cancers

Lee Greenberger, Chief Scientific Officer of LLS

The importance of monitoring COVID-19 in patients with Waldenström’s macroglobulinemia

VJHemOnc – Video Journal of Hematology & HemOnc

AML: A look at the patient experience

Leukemia & Lymphoma Society

Why Immunotherapy Will Be an Important Class of Therapies for Blood Cancers

Combination Therapies for Hematologic Malignancies

Rare Disease Report

Recent Advances & New Opportunities in Blood Cancer Research & Treatment

Leukemia & Lymphoma Society

AML Genetic Testing and Me Webinar

Leukemia & Lymphoma Society

Emerging Immunotherapies for Hematologic Malignancies

Rare Disease Report